Pablo graduated from an MSc in Applied Cancer Science and is currently a DPhil candidate in Advanced Bioscience of Viral Products at the Dunn School of Pathology under the supervision of Omer Dushek and Anton Van der Merwe.
In collaboration with the biotech company Oxford Biomedica, Pablo focuses on the development of lentiviral vectors for CAR T-cell therapies, with the final aim to democratise access to CAR T-cell treatment for various forms of cancer.
In his free time, Pablo enjoys hiking, reading and trying new tasty recipes.
